|
|
| | Benzenesulfonamide, 3-[4-[[6-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]hexyl]oxy]butyl]- Basic information |
| | Benzenesulfonamide, 3-[4-[[6-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]hexyl]oxy]butyl]- Chemical Properties |
| Boiling point | 717.5±70.0 °C(Predicted) | | density | 1.228±0.06 g/cm3(Predicted) | | pka | 9.99±0.20(Predicted) |
| | Benzenesulfonamide, 3-[4-[[6-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]hexyl]oxy]butyl]- Usage And Synthesis |
| Uses | GW-597901 is a compound with bronchodilator activity that has a stronger bronchodilator effect than salbutamol in a human lung reperfusion model, but with a slightly slower onset of action. | | References | [1] Comparison of the bronchodilating effects of inhaled β-agonists after methacholine challenge in a human lung reperfusion model DOI:10.1016/j.ejpb.2012.04.013 |
| | Benzenesulfonamide, 3-[4-[[6-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]amino]hexyl]oxy]butyl]- Preparation Products And Raw materials |
|